Though David bars have their positives, a bar alone isn’t going to magically make you lose fat and gain muscle (no matter ...

In this series, ‘Genomics 101’, we go back to basics and explore some of the most important topics in genomics. In this blog, we explain the term ...

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears undervalued ...

The Patent Eligibility Restoration Act (PERA) proposes a solution to a complex debate: What can be patented, and when do ...

Jay and Pamela both have Osteogenesis Imperfecta Type 3, a condition that causes fragile bones. Both get around in motorized ...

Cystic-fibrosis-focused Sionna Therapeutics is joining the Nasdaq this morning with an upsized public offering, while obesity ...

On Friday, in a significant policy shift, the National Institutes of Health (NIH) announced immediate cuts to grants ...

In December, the Federal Highway Administration awarded the first grants under a new $125 million Wildlife Crossings Pilot ...

In the past few years, romantic movies have begun a resurgence, and lovers of the genre could not be happier. From Ticket to ...

From the brink of Nasdaq delisting last year due to non-compliance with the minimum bid price rule, this clinical-stage biotechnology ...